デフォルト表紙
市場調査レポート
商品コード
1667925

自動・閉鎖型細胞治療処理システム市場- 世界の産業規模、シェア、動向、機会、予測、ワークフロー別、タイプ別、規模別、地域別、競合別、2020-2030年

Automated And Closed Cell Therapy Processing Systems Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Workflow, By Type, By Scale, By Region and Competition, 2020-2030F

出版日
ページ情報
英文 180 Pages
納期
2～3営業日
カスタマイズ可能
自動・閉鎖型細胞治療処理システム市場- 世界の産業規模、シェア、動向、機会、予測、ワークフロー別、タイプ別、規模別、地域別、競合別、2020-2030年
出版日: 2025年02月28日
発行: TechSci Research
ページ情報: 英文 180 Pages
納期: 2～3営業日
GIIご利用のメリット

  • 全表示

  • 概要
  • 目次
概要

世界の自動・閉鎖型細胞治療処理システム市場は、2024年に9億3,108万米ドルと評価され、予測期間中のCAGRは9.37%で、2030年には15億9,730万米ドルに達すると予測されています。

再生医療と細胞治療の魅力の高まりと、その市場開拓における自動化技術に関連する数多くの利点が、市場拡大を促進すると予測されています。さらに、先進治療開発手順へのソフトウェア技術の導入が増加していることも、市場開拓を刺激すると予想されます。さらに、複数の資金調達に支えられた細胞療法製品の開発におけるバイオ医薬品メーカーによる投資の増加は、市場に魅力的な成長見通しをもたらすと考えられています。

市場概要
予測期間 2026-2030年
市場規模：2024年 9億3,108万米ドル
市場規模：2030年 15億9,730万米ドル
CAGR：2025年～2030年 9.37%
急成長セグメント 拡大
最大市場 北米

市場促進要因

再生医療と細胞治療の人気の高まり

主な市場課題

高い初期費用

主要市場動向

効率性と一貫性のための自動化システムの採用増加

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の自動・閉鎖型細胞治療処理システム市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • ワークフロー別（分離、増殖、成分分析、充填・仕上げ、凍結保存、その他）
    • タイプ別（幹細胞療法、非幹細胞療法）
    • 規模別（プレコマーシャル/研究開発規模、商用規模）
    • 地域別
    • 企業別（2024年）
  • 市場マップ

第6章 北米の自動・閉鎖型細胞治療処理システム市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 北米：国別分析
    • 米国
    • カナダ
    • メキシコ

第7章 欧州の自動・閉鎖型細胞治療処理システム市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 欧州：国別分析
    • ドイツ
    • 英国
    • イタリア
    • フランス
    • スペイン

第8章 アジア太平洋地域の自動・閉鎖型細胞治療処理システム市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • アジア太平洋地域：国別分析
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア

第9章 南米の自動・閉鎖型細胞治療処理システム市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 南米：国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第10章 中東・アフリカの自動・閉鎖型細胞治療処理システム市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 中東・アフリカ：国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第11章 市場力学

  • 促進要因
  • 課題

第12章 市場動向と発展

  • 合併と買収（該当する場合）
  • 製品の発売（該当する場合）
  • 最近の動向

第13章 ポーターのファイブフォース分析

  • 業界内の競合
  • 新規参入の可能性
  • サプライヤーの力
  • 顧客の力
  • 代替品の脅威

第14章 競合情勢

  • Miltenyi Biotec B.V. & Co. KG
  • Lonza Group AG
  • Fresenius Kabi AG
  • Global Life Sciences Solutions USA LLC
  • BioSpherix, LLC
  • Terumo Corp
  • Sartorius AG
  • ThermoGenesis Holdings Inc
  • Cellares Corporation
  • Thermo Fisher Scientific Inc

第15章 戦略的提言

第16章 調査会社について・免責事項

目次
Product Code: 19186

Global Automated And Closed Cell Therapy Processing Systems Market has valued at USD 931.08 Million in 2024 and is expected to reach USD 1597.30 Million by 2030 with a CAGR of 9.37% during the forecast period. The increasing appeal of regenerative medicine and cell therapies, along with the numerous advantages associated with automation technologies in their development, is projected to drive market expansion. Moreover, the increasing incorporation of software technologies into advanced therapy development procedures is also expected to stimulate market growth. Additionally, the rising investments made by biopharmaceutical manufacturers in the development of cellular therapy products, supported by multiple rounds of funding, are poised to provide attractive growth prospects for the market.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 931.08 Million
Market Size 2030USD 1597.30 Million
CAGR 2025-20309.37%
Fastest Growing SegmentExpansion
Largest MarketNorth America

Key Market Drivers

Growing Popularity of Regenerative Medicine and Cell Therapies

Regenerative medicine and cell therapies represent a groundbreaking frontier in modern healthcare, offering new hope for treating a variety of challenging medical conditions. As these therapies gain momentum and continue to demonstrate their effectiveness, they are poised to significantly impact the healthcare industry. One crucial factor enabling the scalability and efficiency of regenerative medicine and cell therapy production is the adoption of automated and closed cell therapy processing systems.

The increasing popularity of regenerative medicine and cell therapies has led to a surge in demand for these groundbreaking treatments. However, with greater demand comes the need for efficient, scalable, and consistent manufacturing processes. Automated and closed cell therapy processing systems offer a solution to this challenge. They can handle large-scale production while maintaining precise control over cell culture conditions. This scalability is essential to meet the growing global demand for these therapies. In June 2024, Cryoport Systems, LLC joined forces with Minaris Regenerative Medicine to advance the development of cell and gene therapies. This partnership is centered on offering integrated solutions for the storage, transportation, and processing of cell and gene-based products. The collaboration aims to facilitate the commercialization and clinical trials of regenerative therapies.

Key Market Challenges

High Initial Costs

One of the most significant barriers to the adoption of automated cell therapy processing systems is the high initial cost associated with acquiring and implementing these advanced technologies. The investment required to purchase, install, and configure such systems can be substantial, often running into the millions of dollars. This poses a particular challenge for smaller biotech companies and research institutions that may lack the financial resources to make such large investments. Additionally, the long-term return on investment (ROI) may not be immediately clear, leading to hesitation among potential stakeholders. The financial strain associated with these initial costs can deter many from entering the market or adopting these systems, despite the potential long-term benefits in terms of efficiency, scalability, and precision.

Key Market Trends

Increasing Adoption of Automated Systems for Efficiency and Consistency

The demand for automated cell therapy processing systems is rising globally due to the need for increased efficiency and consistency in manufacturing processes. Cell therapy, which includes innovative treatments such as stem cell and gene therapies, has complex production requirements that necessitate precise control over various parameters, including temperature, oxygen levels, and pH. Traditionally, manual processing could result in variability and human error, which compromises product quality and consistency. Automated systems are designed to standardize processes and reduce errors, ensuring more reliable outcomes.

Key Market Players

  • Miltenyi Biotec B.V. & Co. KG
  • Lonza Group AG
  • Fresenius Kabi AG
  • Global Life Sciences Solutions USA LLC
  • BioSpherix, LLC
  • Terumo Corp
  • Sartorius AG
  • ThermoGenesis Holdings Inc
  • Cellares Corporation
  • Thermo Fisher Scientific Inc.

Report Scope:

In this report, the Global Automated And Closed Cell Therapy Processing Systems Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Automated And Closed Cell Therapy Processing Systems Market, By Workflow:

  • Separation
  • Expansion
  • Apheresis
  • Fill-Finish
  • Cryopreservation
  • Others

Automated And Closed Cell Therapy Processing Systems Market, By Type:

  • Stem Cell Therapy
  • Non-Stem Cell Therapy

Automated And Closed Cell Therapy Processing Systems Market, By Scale:

  • Pre-commercial/ R&D Scale
  • Commercial Scale

Automated And Closed Cell Therapy Processing Systems Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Automated And Closed Cell Therapy Processing Systems Market.

Available Customizations:

Global Automated And Closed Cell Therapy Processing Systems market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Automated And Closed Cell Therapy Processing Systems Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Workflow (Separation, Expansion, Apheresis, Fill-Finish, Cryopreservation, Others)
    • 5.2.2. By Type (Stem Cell Therapy, Non-Stem Cell Therapy)
    • 5.2.3. By Scale (Pre-commercial/ R&D Scale, Commercial Scale)
    • 5.2.4. By Region
    • 5.2.5. By Company (2024)
  • 5.3. Market Map

6. North America Automated And Closed Cell Therapy Processing Systems Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Workflow
    • 6.2.2. By Type
    • 6.2.3. By Scale
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Automated And Closed Cell Therapy Processing Systems Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Workflow
        • 6.3.1.2.2. By Type
        • 6.3.1.2.3. By Scale
    • 6.3.2. Canada Automated And Closed Cell Therapy Processing Systems Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Workflow
        • 6.3.2.2.2. By Type
        • 6.3.2.2.3. By Scale
    • 6.3.3. Mexico Automated And Closed Cell Therapy Processing Systems Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Workflow
        • 6.3.3.2.2. By Type
        • 6.3.3.2.3. By Scale

7. Europe Automated And Closed Cell Therapy Processing Systems Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Workflow
    • 7.2.2. By Type
    • 7.2.3. By Scale
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Automated And Closed Cell Therapy Processing Systems Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Workflow
        • 7.3.1.2.2. By Type
        • 7.3.1.2.3. By Scale
    • 7.3.2. United Kingdom Automated And Closed Cell Therapy Processing Systems Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Workflow
        • 7.3.2.2.2. By Type
        • 7.3.2.2.3. By Scale
    • 7.3.3. Italy Automated And Closed Cell Therapy Processing Systems Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Workflow
        • 7.3.3.2.2. By Type
        • 7.3.3.2.3. By Scale
    • 7.3.4. France Automated And Closed Cell Therapy Processing Systems Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Workflow
        • 7.3.4.2.2. By Type
        • 7.3.4.2.3. By Scale
    • 7.3.5. Spain Automated And Closed Cell Therapy Processing Systems Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Workflow
        • 7.3.5.2.2. By Type
        • 7.3.5.2.3. By Scale

8. Asia-Pacific Automated And Closed Cell Therapy Processing Systems Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Workflow
    • 8.2.2. By Type
    • 8.2.3. By Scale
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Automated And Closed Cell Therapy Processing Systems Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Workflow
        • 8.3.1.2.2. By Type
        • 8.3.1.2.3. By Scale
    • 8.3.2. India Automated And Closed Cell Therapy Processing Systems Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Workflow
        • 8.3.2.2.2. By Type
        • 8.3.2.2.3. By Scale
    • 8.3.3. Japan Automated And Closed Cell Therapy Processing Systems Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Workflow
        • 8.3.3.2.2. By Type
        • 8.3.3.2.3. By Scale
    • 8.3.4. South Korea Automated And Closed Cell Therapy Processing Systems Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Workflow
        • 8.3.4.2.2. By Type
        • 8.3.4.2.3. By Scale
    • 8.3.5. Australia Automated And Closed Cell Therapy Processing Systems Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Workflow
        • 8.3.5.2.2. By Type
        • 8.3.5.2.3. By Scale

9. South America Automated And Closed Cell Therapy Processing Systems Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Workflow
    • 9.2.2. By Type
    • 9.2.3. By Scale
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Automated And Closed Cell Therapy Processing Systems Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Workflow
        • 9.3.1.2.2. By Type
        • 9.3.1.2.3. By Scale
    • 9.3.2. Argentina Automated And Closed Cell Therapy Processing Systems Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Workflow
        • 9.3.2.2.2. By Type
        • 9.3.2.2.3. By Scale
    • 9.3.3. Colombia Automated And Closed Cell Therapy Processing Systems Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Workflow
        • 9.3.3.2.2. By Type
        • 9.3.3.2.3. By Scale

10. Middle East and Africa Automated And Closed Cell Therapy Processing Systems Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Workflow
    • 10.2.2. By Type
    • 10.2.3. By Scale
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Automated And Closed Cell Therapy Processing Systems Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Workflow
        • 10.3.1.2.2. By Type
        • 10.3.1.2.3. By Scale
    • 10.3.2. Saudi Arabia Automated And Closed Cell Therapy Processing Systems Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Workflow
        • 10.3.2.2.2. By Type
        • 10.3.2.2.3. By Scale
    • 10.3.3. UAE Automated And Closed Cell Therapy Processing Systems Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Workflow
        • 10.3.3.2.2. By Type
        • 10.3.3.2.3. By Scale

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products

14. Competitive Landscape

  • 14.1. Miltenyi Biotec B.V. & Co. KG
    • 14.1.1. Business Overview
    • 14.1.2. Company Snapshot
    • 14.1.3. Products & Services
    • 14.1.4. Financials (As Reported)
    • 14.1.5. Recent Developments
    • 14.1.6. Key Personnel Details
    • 14.1.7. SWOT Analysis
  • 14.2. Lonza Group AG
  • 14.3. Fresenius Kabi AG
  • 14.4. Global Life Sciences Solutions USA LLC
  • 14.5. BioSpherix, LLC
  • 14.6. Terumo Corp
  • 14.7. Sartorius AG
  • 14.8. ThermoGenesis Holdings Inc
  • 14.9. Cellares Corporation
  • 14.10. Thermo Fisher Scientific Inc

15. Strategic Recommendations

16. About Us & Disclaimer